MEDITOXIN
MEDITOXIN | |
|---|---|
| Active Ingredient | Clostridium botulinum toxin type A (hall strain) |
| Unit | 50 units, 100units, 150units |
| Storage Method | Store in frozen (below -5°C ) or refrigeration ( 2-8°C ) condition |
| Shelf-life | 36months from manufacturing date (Reconstituted product has a shelf-life of 24 hours in refrigeration condition (2-8°C) |
| Package Unit | 1 vial |
| Product Classification | Prescription Medicine |
| Product Appearance | Injectable lyophilized white powder filled in colorless, Transparent vial |
| Indications | •Benign essential blepharospasm in adult patients aged 18 years or older. •Treatment of equines foot deformity due to spasticity in pediatric cerebral Palsy patients aged 2 years or older. •Temporary improvement of moderate to severe glabellar wrinkles Associated with corrugators muscle and/or procerus muscle activities in adults over the age 20 and below the age of 65 •Muscle spasticity : Upper limb spasticity associated with stroke in patients aged 20 or older |
MEDITOXIN
SPECIFICATION
MEDITOXIN | |
|---|---|
| Active Ingredient | Clostridium botulinum toxin type A (hall strain) |
| Unit | 50 units, 100units, 150units, 200units |
| Storage Method | Store in frozen (below -5°C ) or refrigeration ( 2-8°C ) condition |
| Shelf-life | 36months from manufacturing date ( Reconstituted product has a shelf-life of 24 hours in refrigeration condition (2-8°C) |
| Package Unit | 1 vial |
| Product Classification | Prescription Medicine |
| Product Appearance | Injectable lyophilized white powder filled in colorless, Transparent vial |
| Indications | •Benign essential blepharospasm in adult patients aged 18 years or older. •Treatment of equine foot deformity due to spasticity in pediatric cerebral Palsy patients aged 2 years or older. •Temporary improvement of moderate to severe glabellar wrinkles Associated with corrugators muscle and/or procerus muscle activities in adults over the age 20 and below the age of 65 •Muscle spasticity : Upper limb spasticity associated with stroke in patients aged 20 or older |
